Clinical Trial LIMS
The benefits of Matrix systems include:
- Fully configurable software means that Matrix systems are implemented to your specific requirements - leading to fast acceptance of the system
- The dual Windows/Browser interface means you can use the most appropriate interface for the current task
- The One-time Configuration Tools mean that both desktop and browser screens change as a result of a single action; no separate editing is required for each platform
- Matrix systems are scalable so they can be used on a single laboratory/site or across multiple sites; remote access is standard
- Matrix systems are fully supported by our in-house Help Desk, staffed by Matrix Gemini configuration experts so you can speak to an expert
Matrix Tracker has been implemented as a sample/tissue tracking solution for clinical trials management. These studies can generate many thousands of samples of different types, tissue, blood and other body fluids all of which need to be tracked and, if necessary, traced. The system must cover sample collection, chain of custody, storage, retrieval, test result data and provide reporting for the trials and studies. Another important aspect of these trials is the inventory management of the components use to assemble the sampling kits used to collect samples. Finally, Matrix Tracker will help you to comply with the requirements that need to be met when operating in a regulated environment.
Matrix Tracker functionality for clinical trials management includes:
- Compliance with regulatory authority guidelines (e.g. HTA, GCLP, MHRA, FDA 21 CFR Part 11 and other similar requirements)
- Full sample tracking including parent/child samples, aliquots, derivatives etc.
- Complete location recording e.g. room, freezer, shelf, container and position within the container
- Storage location auditing and reconciliation
- Inventory management for assembly of sampling kits
- Audit trail of all system and data changes
- Barcode compatibility
- Dual Windows/Browser user interface
For more information on our Clinical trials LIMS




